openPR Logo
Press release

Vulvar Cancer Market 2017: Key Players – Abbott Diagnostics, Ono pharmaceutical co ltd,PDS Biotechnology Corporation, Becton Dickinson and Company, Siemens Healthcare

12-26-2017 02:44 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Vulvar Cancer Treatment

Vulvar Cancer Treatment

Market Research Future published a research report on “Vulvar Cancer market”-Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023

Vulvar cancer is a rare type of cancer. It forms in a woman’s external genitals, called the vulva. Being a rare disease it accounts for only 0.6- 0.7 % of total cancer diagnosis. Vulvar cancer can affect any part of the female genitalia, but usually affects the labia.

Global Vulvar Cancer Market Research Report, by Types (adenocarcinoma, squamous cell carcinomas, melanoma, sarcoma), by Treatment (radiation therapy, chemotherapy, surgery, drug treatment) and by End User (hospitals and clinics, cancer research institutes) - Forecast Till 2023

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1423

Segmentation

Global vulvar cancer market is segmented

On the basis of vulvar cancer which includes adenocarcinoma, squamous cell carcinomas, melanoma, sarcomaand other.
On the basis of treatment the market is segmented as radiation therapy, chemotherapy, surgery and drugs treatment. Surgery is further sub segmented into excision, radical vulvectomy, partial vulvectomy and other.
On the basis of end user the market is segmented into hospitals and clinics, cancer research institutes and other.
Market Synopsis

Vulvar cancer is a rare disease that comprises of a malignant and invasive growth in the vulva. Being a rare disease it accounts for only 0.6- 0.7 % of total cancer diagnosis. Labia majora is the common site of this cancer as compared to labia minora. The major driving factor for this market is increasing prevalence of different types of like vulvar and vaginal cancer and changing lifestyle which is responsible for causing this cancer. On other hand high price associated with this disease and number of adverse effect of treatment may hamper the growth of this market.

Global vulvar cancer market is expected to grow at a CAGR of 5.8% during forecasted period of 2017-2023.

Key Players

This market has various players, some of the key players in this market are

Abbott Diagnostics (US)
Ono pharmaceutical co ltd (Japan)
PDS Biotechnology Corporation (US)
Becton Deckinson and Company (US)
Siemens Healthcare (Germany)
Qiagen (Germany)
ISA Pharmaceuticals B.V. (Netherland)
ORYX GmbH & Co. KG (Germany)
PfizerInc(US)
(US)
Johnson & Johnson (US)
Novartis AG (Switzerland)
Hoffmann-La Roche Ltd (Switzerland)
Celgene Corporation (US)
Merck&Co.(US)
Browse Full Report @ https://www.marketresearchfuture.com/reports/vulvar-cancer-market

Table of Content

1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 MARKET DYNAMICS
4 MARKET FACTOR ANALYSIS
5. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY DEVICE TYPE
6. ABLATION DEVICES.
7. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION
8. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY REGION
9. COMPETITIVE LANDSCAPE
10 COMPANY PROFILE

Regional Analysis

On regional basis the global vulvar cancer market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America contribute the largest share in the market of vulvar cancer. Due to increasing prevalence of cancer in this region this market is expecting a swift growth. Europe is the second largest market followed by Asia Pacific. The outstanding development of healthcare sector in Asia Pacific region, it is responsible for the highest growth rate of this market in this region.

The report of global vulvar cancer market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of different markets segments and regions.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for North America, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vulvar Cancer Market 2017: Key Players – Abbott Diagnostics, Ono pharmaceutical co ltd,PDS Biotechnology Corporation, Becton Dickinson and Company, Siemens Healthcare here

News-ID: 875897 • Views:

More Releases from Market Research Future

Intelligent Process Automation Market to Reach USD 30 Billion by 2035, Growing at 11.58% CAGR
Intelligent Process Automation Market to Reach USD 30 Billion by 2035, Growing a …
The Intelligent Process Automation Market is poised for sustained expansion, with its value rising from USD 8.99 billion in 2024 to USD 30.0 billion by 2035. This growth reflects a strong compound annual growth rate (CAGR) of 11.58% between 2025 and 2035. Intelligent process automation combines robotic process automation, artificial intelligence, natural language processing, and machine learning to create adaptive, efficient, and resilient business processes. Its adoption is accelerating as
Chinese Language Education for K-12 Market to Grow at 12.8% CAGR, Hitting USD 16 …
The Chinese Language Education for K-12 Market is experiencing robust expansion as global interest in Chinese language proficiency continues to rise. According to Market Research Future, the market size was valued at USD 4,400.48 million in 2024 and is projected to grow from USD 4,941.74 million in 2025 to USD 16,612.10 million by 2035. This trajectory reflects a strong compound annual growth rate (CAGR) of 12.8% during the forecast period
Computer Aided Engineering Market to Reach USD 28.78 Billion by 2035, Growing at …
The Computer Aided Engineering Market is entering a decade of strong expansion, underpinned by the growing demand for simulation technologies, design optimization, and advanced product development across industries. According to Market Research Future, the Computer Aided Engineering Market was valued at USD 11.09 billion in 2024 and is projected to grow from USD 11.83 billion in 2025 to USD 28.78 billion by 2035, reflecting a robust compound annual growth rate
B2B Cybersecurity Market to Hit USD 29.52 Billion by 2034, Growing at 14.32% CAGR Forecast Period
B2B Cybersecurity Market to Hit USD 29.52 Billion by 2034, Growing at 14.32% CAG …
As per Market Research Future Analysis, the B2B Cybersecurity Market is set for remarkable expansion, projected to grow from USD 8,853.54 Million in 2025 to USD 29,527.37 Million by 2034, achieving a compound annual growth rate (CAGR) of 14.32% during the forecast period. The market was valued at USD 7,744.50 Million in 2024, demonstrating a strong base of demand driven by the rising frequency of cyberattacks, growing regulatory pressure, and

All 5 Releases


More Releases for Vulvar

Vulvar Cancer Market is expected to nearly double by 2034, reaching USD 850 mill …
Vulvar cancer is a rare gynecologic malignancy that arises on the external female genitalia, most commonly as squamous cell carcinoma, though melanoma, adenocarcinoma, and sarcoma subtypes also occur. While it accounts for only 4-5% of all gynecologic cancers, vulvar cancer is associated with significant morbidity, especially when diagnosed late. Risk factors include human papillomavirus (HPV) infection, lichen sclerosus, smoking, and advancing age. Download Full PDF Sample Copy of Market Report @
Global Vulvar and Vaginal Atrophy Therapy Market Imapct of AI and Automation
Vulvar and Vaginal Atrophy Therapy Market Impact of AI and Automation The Vulvar and Vaginal Atrophy (VVA) therapy market experienced a substantial valuation in 2022, with the market size reaching approximately USD 1.2 billion. This growth reflects a compound annual growth rate (CAGR) of around 6.8% from 2021 to 2022. The demand for VVA therapies has been driven by an increasing prevalence of postmenopausal women and the rising awareness of available
Vulvar Cancer Market 2024 Size, Global Report till 2031 | Pfizer Inc., ISA Pharm …
A new Report by DataM Intelligence, titled " Vulvar Cancer Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Vulvar Cancer market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Vulvar Cancer market
Global Vulvar Cancer Market Competitive landscape, Company profile By 2016- 2023
Market Highlights Global vulvar cancer market at a CAGR of 5.8% during forecasted period 2017-2023 Vulvar cancer is squamous cell skin cancer that occurs in elderly women. It is one of the rare type of cancer and the 4th common gynecologic cancer. Human papillomavirus infection, vulvar intraepithelial neoplasia, heavy cigarette smoking and many other things are major risk factors for this diseases. Beside these women suffering from HIV are also prone to
Vulvar Cancer Market Research in-Depth Analysis, Worldwide Forecast 2027
Market Research Future published a Half-Cooked Research Report on Global Vulvar Cancer Information, by types, by type of treatment, by end users, Forecast 2027 Intended Audience • Vulvar Cancer drug manufacturers • Vulvar Cancer drug Suppliers • Pharmaceutical companies • Research and Development (R&D) Companies • Medical Research Laboratories • Academic Medical Institutes and Universities Market Scenario: Vulvar cancer is an uncommon disease in which cancer cells structure in the tissues of the vulva having vulvar intraepithelial neoplasia or HPV contamination which can influence the
Vulvar Cancer Market : Evolving Technology, Trends And Industry Analysis – 202 …
Global Vulvar Cancer Information, by types (squamous cell carcinomas, vulvar intraepithelial neoplasia (VIN), human papillomavirus (HPV) by type of treatment (Removal of lymph nodes, radiation therapy, chemotherapy, Neoadjuvant chemoradiation, drugs) by end users (hospitals, cancer research centers, clinics) - Forecast to 2027 Market Synopsis of Vulvar Cancer Market: Market Scenario: Vulvar cancer is an uncommon disease in which cancer cells structure in the tissues of the vulva having vulvar intraepithelial neoplasia